JP2005519028A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519028A5 JP2005519028A5 JP2003543594A JP2003543594A JP2005519028A5 JP 2005519028 A5 JP2005519028 A5 JP 2005519028A5 JP 2003543594 A JP2003543594 A JP 2003543594A JP 2003543594 A JP2003543594 A JP 2003543594A JP 2005519028 A5 JP2005519028 A5 JP 2005519028A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- adamantylmethyl
- chloro
- propyl
- isonicotinamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *c1cnc(*)c(*)c1* Chemical compound *c1cnc(*)c(*)c1* 0.000 description 5
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103836A SE0103836D0 (sv) | 2001-11-16 | 2001-11-16 | Novel compounds |
| PCT/SE2002/002057 WO2003041707A1 (en) | 2001-11-16 | 2002-11-12 | N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005519028A JP2005519028A (ja) | 2005-06-30 |
| JP2005519028A5 true JP2005519028A5 (https=) | 2009-12-24 |
| JP4559077B2 JP4559077B2 (ja) | 2010-10-06 |
Family
ID=20286020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003543594A Expired - Fee Related JP4559077B2 (ja) | 2001-11-16 | 2002-11-12 | 医薬組成物としてのｎ−アダマンチルメチル誘導体および中間体、ならびにそれらの製造方法 |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7129246B2 (https=) |
| EP (1) | EP1448195B1 (https=) |
| JP (1) | JP4559077B2 (https=) |
| KR (1) | KR20040058290A (https=) |
| CN (1) | CN1585640B (https=) |
| AR (1) | AR037534A1 (https=) |
| AT (1) | ATE344034T1 (https=) |
| AU (1) | AU2002347741B2 (https=) |
| BR (1) | BR0214142A (https=) |
| CA (1) | CA2464863A1 (https=) |
| CO (1) | CO5580747A2 (https=) |
| DE (1) | DE60215851T2 (https=) |
| DK (1) | DK1448195T3 (https=) |
| ES (1) | ES2274110T3 (https=) |
| HU (1) | HUP0402560A3 (https=) |
| IL (1) | IL161693A0 (https=) |
| IS (1) | IS7261A (https=) |
| MX (1) | MXPA04004498A (https=) |
| MY (1) | MY136430A (https=) |
| NO (1) | NO20042155L (https=) |
| NZ (1) | NZ532755A (https=) |
| PL (1) | PL370855A1 (https=) |
| PT (1) | PT1448195E (https=) |
| RU (1) | RU2300525C2 (https=) |
| SE (1) | SE0103836D0 (https=) |
| TW (1) | TW200407297A (https=) |
| UA (1) | UA77978C2 (https=) |
| WO (1) | WO2003041707A1 (https=) |
| ZA (1) | ZA200403682B (https=) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI258462B (en) | 1999-12-17 | 2006-07-21 | Astrazeneca Ab | Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same |
| GB0013737D0 (en) | 2000-06-07 | 2000-07-26 | Astrazeneca Ab | Novel compounds |
| SE0200920D0 (sv) * | 2002-03-25 | 2002-03-25 | Astrazeneca Ab | Novel compounds |
| SE0300480D0 (sv) | 2003-02-21 | 2003-02-21 | Astrazeneca Ab | Novel compounds |
| WO2004105797A1 (en) * | 2003-05-29 | 2004-12-09 | Astrazeneca Ab | A pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine |
| TW200507829A (en) * | 2003-05-29 | 2005-03-01 | Astrazeneca Ab | New combination |
| EP1644042A1 (en) * | 2003-05-29 | 2006-04-12 | AstraZeneca AB | A pharmaceutical composition containing a p2x7 receptor antagonist and methotrexate |
| GB0312609D0 (en) * | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
| KR100554155B1 (ko) * | 2003-06-09 | 2006-02-22 | 학교법인 포항공과대학교 | 금속/반도체 나노막대 이종구조를 이용한 전극 구조물 및그 제조 방법 |
| SE0302139D0 (sv) * | 2003-07-28 | 2003-07-28 | Astrazeneca Ab | Novel compounds |
| SE0302192D0 (sv) * | 2003-08-08 | 2003-08-08 | Astrazeneca Ab | Novel compounds |
| SE0302488D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | New combination |
| SA05260265A (ar) * | 2004-08-30 | 2005-12-03 | استرازينيكا ايه بي | مركبات جديدة |
| SE0402925D0 (sv) * | 2004-11-30 | 2004-11-30 | Astrazeneca Ab | Novel Compounds |
| EA201300152A1 (ru) | 2006-11-27 | 2013-07-30 | Х. Лундбекк А/С | Гетероариламидные производные |
| BRPI0809106A2 (pt) * | 2007-03-22 | 2014-08-26 | Astrazeneca Ab | Derivados de quinolina para o tratamento de doenças inflamatórias |
| BRPI0809567A2 (pt) | 2007-04-10 | 2014-09-23 | Lundbeck & Co As H | Composto, composição farmacêutica, método para modular a atividade de um receptor de p2x7, para tratar uma condição responsiva à modulação do receptor de p2x7 em um paciente, para inibir a morte de células do gânglio retinal em um paciente, e para determinar a presença ou ausência do receptor de p2x7 em uma amostra, preparação farmacêutica acondiciaonada, e, uso de um composto |
| US8106073B2 (en) | 2007-11-30 | 2012-01-31 | Astrazeneca Ab | Quinoline derivatives 057 |
| CN102046240B (zh) | 2008-03-25 | 2014-06-25 | 阿费克蒂斯药品公司 | 新的p2x7r拮抗剂及其应用 |
| WO2010118921A1 (en) | 2009-04-14 | 2010-10-21 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| EP2569281A1 (en) | 2010-05-14 | 2013-03-20 | Affectis Pharmaceuticals AG | Novel methods for the preparation of p2x7r antagonists |
| WO2012110190A1 (en) | 2011-02-17 | 2012-08-23 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| WO2012163792A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| WO2012163456A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| CN103687860B (zh) | 2011-07-22 | 2016-06-08 | 埃科特莱茵药品有限公司 | 作为p2x7受体拮抗剂的杂环酰胺衍生物 |
| EA024204B1 (ru) | 2012-01-20 | 2016-08-31 | Актелион Фармасьютиклз Лтд. | Производные гетероциклических амидов в качестве антагонистов p2xрецептора |
| KR101576235B1 (ko) * | 2012-11-30 | 2015-12-11 | 한국생명공학연구원 | 신규한 이치환 아다만틸 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 암 전이 억제용 약학적 조성물 |
| AR093921A1 (es) | 2012-12-12 | 2015-06-24 | Actelion Pharmaceuticals Ltd | Derivados de indol carboxamida como antagonistas del receptor p2x7 |
| KR102232744B1 (ko) | 2012-12-18 | 2021-03-26 | 이도르시아 파마슈티컬스 리미티드 | Ｐ２ｘ７ 수용체 길항제로서의 인돌 카르복사미드 유도체 |
| KR102222220B1 (ko) | 2013-01-22 | 2021-03-03 | 이도르시아 파마슈티컬스 리미티드 | Ｐ2ｘ7 수용체 길항제로서의 헤테로시클릭 아미드 유도체 |
| ES2616883T3 (es) | 2013-01-22 | 2017-06-14 | Actelion Pharmaceuticals Ltd. | Derivados amida heterocíclicos como antagonistas del receptor P2X7 |
| CN104163795B (zh) * | 2014-08-19 | 2016-02-03 | 四川大学 | 盐酸烟酰美金刚胺溶剂合物、其制备方法和用途 |
| CN104628617B (zh) * | 2015-02-12 | 2016-04-06 | 佛山市赛维斯医药科技有限公司 | N-金刚烷酰胺类葡萄糖激酶活化剂、制备方法及其用途 |
| CN104628616B (zh) * | 2015-02-12 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 含对硝基苯基的n-金刚烷酰胺类化合物、其制备方法及用途 |
| CN104693084B (zh) * | 2015-02-12 | 2016-03-16 | 佛山市赛维斯医药科技有限公司 | 含腈基苯基的n-金刚烷酰胺类化合物、其制备方法及用途 |
| CN104628615B (zh) * | 2015-02-12 | 2016-04-06 | 佛山市赛维斯医药科技有限公司 | 含卤代苯的n-金刚烷酰胺类化合物、其制备方法及其用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3352912A (en) * | 1963-07-24 | 1967-11-14 | Du Pont | Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes |
| US3471491A (en) | 1967-08-28 | 1969-10-07 | Squibb & Sons Inc | Adamantyl-s-triazines |
| US3464998A (en) | 1968-03-04 | 1969-09-02 | Searle & Co | Adamantyl esters and amides of pyridinecarboxylic acids |
| GB1274652A (en) * | 1968-08-27 | 1972-05-17 | Lilly Industries Ltd | Adamantanyl-alkylamine derivatives and their preparation |
| US4027035A (en) * | 1968-08-27 | 1977-05-31 | Eli Lilly And Company | Therapeutic uses of adamantanealkylamine compounds |
| IL53441A0 (en) * | 1977-11-22 | 1978-01-31 | Teva Pharma | Methyladamantyl hydrazines their preparation and pharmaceutical compositions containing them |
| US4751292A (en) * | 1985-07-02 | 1988-06-14 | The Plant Cell Research Institute, Inc. | Adamantyl purines |
| EP0424538A4 (en) * | 1989-03-10 | 1992-07-22 | Idemitsu Kosan Company Limited | Pyridine derivatives and their salts, and insecticidal/acaricidal agent containing the same as active ingredient |
| PL181782B1 (pl) | 1993-08-10 | 2001-09-28 | Black James Foundation | Nowe zwiazki i sposób wytwarzania nowych zwiazków PL |
| US6034136A (en) * | 1997-03-20 | 2000-03-07 | Novartis Ag | Certain cyclic thio substituted acylaminoacid amide derivatives |
| FR2761358B1 (fr) * | 1997-03-27 | 1999-05-07 | Adir | Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| SE9704544D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
| SE9704545D0 (sv) * | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
| CN1147483C (zh) | 1999-04-09 | 2004-04-28 | 阿斯特拉曾尼卡有限公司 | 金刚烷衍生物 |
| GB0013737D0 (en) | 2000-06-07 | 2000-07-26 | Astrazeneca Ab | Novel compounds |
| SE0200920D0 (sv) | 2002-03-25 | 2002-03-25 | Astrazeneca Ab | Novel compounds |
-
2001
- 2001-11-16 SE SE0103836A patent/SE0103836D0/xx unknown
-
2002
- 2002-11-07 TW TW091132764A patent/TW200407297A/zh unknown
- 2002-11-12 PL PL02370855A patent/PL370855A1/xx not_active Application Discontinuation
- 2002-11-12 PT PT02783941T patent/PT1448195E/pt unknown
- 2002-11-12 DK DK02783941T patent/DK1448195T3/da active
- 2002-11-12 AT AT02783941T patent/ATE344034T1/de not_active IP Right Cessation
- 2002-11-12 NZ NZ532755A patent/NZ532755A/en unknown
- 2002-11-12 JP JP2003543594A patent/JP4559077B2/ja not_active Expired - Fee Related
- 2002-11-12 MX MXPA04004498A patent/MXPA04004498A/es active IP Right Grant
- 2002-11-12 CA CA002464863A patent/CA2464863A1/en not_active Abandoned
- 2002-11-12 DE DE60215851T patent/DE60215851T2/de not_active Expired - Lifetime
- 2002-11-12 WO PCT/SE2002/002057 patent/WO2003041707A1/en not_active Ceased
- 2002-11-12 KR KR10-2004-7007397A patent/KR20040058290A/ko not_active Ceased
- 2002-11-12 IL IL16169302A patent/IL161693A0/xx unknown
- 2002-11-12 HU HU0402560A patent/HUP0402560A3/hu unknown
- 2002-11-12 ES ES02783941T patent/ES2274110T3/es not_active Expired - Lifetime
- 2002-11-12 US US10/495,711 patent/US7129246B2/en not_active Expired - Fee Related
- 2002-11-12 EP EP02783941A patent/EP1448195B1/en not_active Expired - Lifetime
- 2002-11-12 CN CN028225171A patent/CN1585640B/zh not_active Expired - Fee Related
- 2002-11-12 BR BR0214142-6A patent/BR0214142A/pt not_active IP Right Cessation
- 2002-11-12 RU RU2004112780/04A patent/RU2300525C2/ru not_active IP Right Cessation
- 2002-11-12 AU AU2002347741A patent/AU2002347741B2/en not_active Ceased
- 2002-11-14 MY MYPI20024270A patent/MY136430A/en unknown
- 2002-11-15 AR ARP020104406A patent/AR037534A1/es unknown
- 2002-12-11 UA UA20040503316A patent/UA77978C2/uk unknown
-
2004
- 2004-05-11 CO CO04043373A patent/CO5580747A2/es not_active Application Discontinuation
- 2004-05-13 IS IS7261A patent/IS7261A/is unknown
- 2004-05-13 ZA ZA200403682A patent/ZA200403682B/xx unknown
- 2004-05-25 NO NO20042155A patent/NO20042155L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005519028A5 (https=) | ||
| JP4559077B2 (ja) | 医薬組成物としてのｎ−アダマンチルメチル誘導体および中間体、ならびにそれらの製造方法 | |
| US6043284A (en) | Anti-atherosclerotic diaryl compounds | |
| DE60036968T2 (de) | Adamantanderivate zur Behandlung von entzündlichen, immunologischen und kardiovaskulären Erkrankungen | |
| AU2002347741A1 (en) | N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation | |
| US4226878A (en) | Imidazole derivative | |
| TWI254038B (en) | N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD | |
| KR20100132073A (ko) | Ｐａｉ―１ 저해제 | |
| JP2004506611A5 (https=) | ||
| KR20110019440A (ko) | 아폽토시스 프로모터 ａｂｔ－２６３의 제조 방법 | |
| JP3179599B2 (ja) | 縮合ベンゼンオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤 | |
| US20240400532A1 (en) | Nitric oxide releasing prodrugs of mda and mdma | |
| JP2015516968A5 (https=) | ||
| JPH04507421A (ja) | ５―（１―アミノシクロヘキシル）―２（１ｈ）―ピリジノン及び関連化合物 | |
| NZ201479A (en) | N-phenethyl-alpha,omega-alkylenediamines and pharmaceutical compositions | |
| CA3214066A1 (en) | 1,3-substituted cyclobutyl derivatives and uses thereof | |
| JP2001240581A (ja) | アミノベンズアミド誘導体およびその用途 | |
| KR20010101818A (ko) | (1-페나시-3-페닐-3-피페리딜에틸)피페리딘 유도체, 그의제조 방법 및 이를 함유하는 제약 조성물 | |
| JPH07165681A (ja) | １，３−ベンゼンジメタンアミン誘導体 | |
| JP2024102016A (ja) | 複素環化合物の医薬用途 | |
| JP2024525719A (ja) | 複素環化合物 | |
| BR122025005591B1 (pt) | Uso de e processo para preparação de derivados de ciclobutila 1,3- substituída, combinação farmacêutica, e kit | |
| EA050893B1 (ru) | Производные 1,3-замещенного циклобутила и способы их применения | |
| BR122025005591A2 (pt) | Uso de e processo para preparação de derivados de ciclobutila 1,3-substituída, combinação farmacêutica, e kit | |
| BR112023019496B1 (pt) | Derivados de ciclobutila 1,3-substituída, e composição farmacêutica |